Kiniksa Pharmaceuticals International Plc (KNSA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -21,612 | -17,704 | 14,084 | -11,153 | 2,702 |
| Depreciation Amortization | 896 | 466 | 2,341 | 1,801 | 1,198 |
| Income taxes - deferred | 14,934 | 4,365 | -33,788 | -8,079 | -18,367 |
| Accounts receivable | 815 | 5,271 | -8,606 | 9,619 | -11,990 |
| Accounts payable and accrued liabilities | -933 | -2,662 | 347 | -6,887 | -7,251 |
| Other Working Capital | -1,332 | 8,578 | 1,350 | 5,311 | -5,703 |
| Other Operating Activity | 16,387 | 5,673 | 37,573 | 18,364 | 31,401 |
| Operating Cash Flow | $9,155 | $3,987 | $13,301 | $8,976 | $-8,010 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -21,214 | 25,608 | -29,427 | -14,589 | -2,328 |
| PPE Investments | -59 | -84 | -130 | -74 | -58 |
| Investing Cash Flow | $-21,273 | $25,524 | $-29,557 | $-14,663 | $-2,386 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 5,129 | 3,994 | 3,701 | 2,744 | 1,087 |
| Other Financing Activity | -1,694 | -381 | -2,206 | -1,944 | -839 |
| Financing Cash Flow | $3,435 | $3,613 | $1,495 | $800 | $248 |
| Beginning Cash Position | 107,954 | 107,954 | 122,715 | 122,715 | 122,715 |
| End Cash Position | 99,271 | 141,078 | 107,954 | 117,828 | 112,567 |
| Net Cash Flow | $-8,683 | $33,124 | $-14,761 | $-4,887 | $-10,148 |
| Free Cash Flow | |||||
| Operating Cash Flow | 9,155 | 3,987 | 13,301 | 8,976 | -8,010 |
| Capital Expenditure | -84 | -84 | -130 | -74 | -58 |
| Free Cash Flow | 9,071 | 3,903 | 13,171 | 8,902 | -8,068 |